MDS Presidential Perspective: Musings on Disease Modification for Parkinson's Disease - Presented by Dr. Anthony Lang

Introduction

MDS Presidential Perspective: Musings on Disease Modification for Parkinson's Disease - Presented by Dr. Anthony Lang

Course Format

Webinar

Release Date

December 02, 2020

Expiration Date

December 31, 2022

Program Description

The MDS Presidential Perspective: Musings on Disease Modification for Parkinson's Disease - Presented by Dr. Anthony Lang webinar will summarize the reasons for believing that "one drug will not fit all" for disease modification in Parkinson's disease and will highlight the related hypothesis that initial involvement of the substantia nigra (e.g., Braak Stage 3) may trigger an accelerated process driven by factors unique to dopaminergic neurons independent of the status of alpha synuclein aggregation.

Faculty

Anthony Lang, OC, MD, FRCPC - University of Toronto, Toronto, Canada

Course Purpose

The primary purpose of this webinar is to provide information on disease modification in Parkinson's disease.

Learning Objectives

Upon completion of this activity learners will be able to:
1. Understand the various types of heterogeneity of Parkinson’s disease
2. Recognize the need to consider combinations of disease modifying therapies (i.e. cocktails)
3. Consider the possibility that the initial involvement of dopaminergic neurons in PD may trigger an accelerated process that may proceed independent of ongoing spread and toxicity of alpha synuclein

Intended Audience

This activity is intended for clinical and basic neuroscientists interested in disease modification in Parkinson’s disease.

Method of Participation

The course must be attended in their entirety. Partial credit is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.

Faculty Disclosure

PRESWEB7-Discl

Accreditation and Credit Designation

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The International Parkinson and Movement Disorder Society designates this education activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Hardware and Software Requirement

1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher).
5. Adobe Reader to print certificate.

Staff Disclosure

MDS staff members involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Disclaimer

All individuals in control of content for this course are required to disclose all relevant financial relationships with commercial interests as defined by the ACCME.